Cargando…

The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263252/ https://www.ncbi.nlm.nih.gov/pubmed/35812280 http://dx.doi.org/10.1016/j.ekir.2022.05.014

Ejemplares similares

The spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad
por: Finsterer, Josef
Publicado: (2021)

In Reply to “The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad”
por: Imasawa, Toshiyuki, et al.
Publicado: (2022)

Autism spectrum disorder: A mitochondrial disorder
por: FINSTERER, Josef
Publicado: (2021)

The Broad Spectrum of Neuro-Radiological Abnormalities in Patients Infected with SARS-CoV-2 Supports the Diagnosis of Neuro-COVID-19
por: Finsterer, Josef
Publicado: (2022)

Mitochondrial disorders are prone to propofol infusion syndrome
por: Finsterer, Josef
Publicado: (2020)

Presentation of Neuro-COVID is Broad and Pathogenesis Diverse
por: Finsterer, Josef
Publicado: (2021)

Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed()()()()
por: Finsterer, Josef, et al.
Publicado: (2017)

Doping May Be Responsible forDe Novo Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2019)

POLG1-related Mitochondrial Disorder with MNGIE- and Leigh-like Features
por: Finsterer, Josef
Publicado: (2020)

Letter to the Editor: Endocrine Compromise in Mitochondrial Disorders
por: Finsterer, Josef, et al.
Publicado: (2018)

Primary Pulmonary Hypertension as a Manifestation of Adult Multi-System Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2009)

Aseptic meningitis as a manifestation of a mitochondrial disorder
por: Finsterer, Josef, et al.
Publicado: (2016)

Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially?
por: Finsterer, Josef
Publicado: (2018)

Neonatal pulmonary hypertension in mitochondrial disorders due to TMEM70 mutations
por: Finsterer, Josef, et al.
Publicado: (2014)

MicroRNAs are inappropriate for characterising hearing impairment in mitochondrial disorders
por: Finsterer, Josef, et al.
Publicado: (2018)

Multisystem mitochondrial disorder is more prevalent than BGC1 variants in patients with Fahr's syndrome
por: Finsterer, Josef
Publicado: (2019)

Treating mitochondrial disorders requires full exploitation of available therapeutic options
por: Finsterer, Josef, et al.
Publicado: (2017)

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
por: Finsterer, Josef
Publicado: (2019)

Imaging abnormalities in pediatric neuro-COVID are more diverse than specified
por: Finsterer, Josef
Publicado: (2022)

The Spectrum of Neuro-COVID is Broader than Frequently Anticipated
por: Finsterer, Josef
Publicado: (2023)

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene()
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial disorders due to m.3243A>G not meeting diagnostic criteria for MELAS require comprehensive work-up
por: Finsterer, Josef, et al.
Publicado: (2023)

Psychiatric abnormalities in COVID-19 patients should prompt work-up for neuro-COVID
por: Finsterer, Josef
Publicado: (2023)

Mitochondrial Ophthalmoplegia Is Not Only due to mtDNA Deletions
por: Finsterer, Josef
Publicado: (2019)

Anti-mitochondrial antibody–mediated myopathy with cardiac involvement
por: Finsterer, Josef
Publicado: (2023)

Diabetes due to Mitochondrial Adipopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome
por: Finsterer, Josef, et al.
Publicado: (2018)

Autosomal Recessive Mitochondrial Myopathy due to MICU-1 Variants
por: Finsterer, Josef
Publicado: (2023)

Broad-spectrum abnormal localized photosensitivity syndrome
por: Butt, Sanaa, et al.
Publicado: (2021)

TK2-related mitochondrial disorder is not restricted to the skeletal muscle
por: Finsterer, Josef, et al.
Publicado: (2018)

Mitochondrial myopathy plus due to the variant m.586G > A in MT-TF
por: Finsterer, Josef
Publicado: (2019)

Phenotypic spectrum of FARS2-deficiency
por: Finsterer, Josef, et al.
Publicado: (2017)

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
por: Finsterer, Josef, et al.
Publicado: (2017)

Whole exome sequencing may be insufficient to cover the causality spectrum of rhabdomyolysis
por: Finsterer, Josef, et al.
Publicado: (2018)

Familial Intracranial Aneurysm Requires Not Only Whole-Exome Sequencing, But Also Mitochondrial DNA Sequencing
por: Finsterer, Josef
Publicado: (2022)

Fractal genetics and heterogeneous phenotypes of mitochondrial disease require appropriate logistics of managing network structures
por: Finsterer, Josef
Publicado: (2019)

Anti-mitochondrial M2 Antibodies and Myopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial cardioencephalopathy due to a COQ4 mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Comment on “CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions”
por: Finsterer, Josef
Publicado: (2020)

Diagnosing mitochondrial, neurogastrointestinal leukoencephalopathy requires mutations in TYMP1, POLG1, LIG1, or RRM2B
por: Finsterer, Josef
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mphkm7iiqu4hbkpijo1t0l9beo